Redmile Group, LLC Shattuck Labs, Inc. Transaction History
Redmile Group, LLC
- $822 Million
- Q2 2025
A detailed history of Redmile Group, LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 5,539,724 shares of STTK stock, worth $11 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
5,539,724
Previous 5,539,724
-0.0%
Holding current value
$11 Million
Previous $5.26 Million
16.84%
% of portfolio
0.53%
Previous 0.55%
Shares
3 transactions
Others Institutions Holding STTK
# of Institutions
64Shares Held
30.4MCall Options Held
36KPut Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$13.1 Million1.42% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$9.26 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.25 Million0.0% of portfolio
-
Clark Estates Inc New York, NY1.48MShares$2.92 Million0.36% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $83.9M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...